524502 — Raaj Medisafe India Income Statement
0.000.00%
- IN₹1.15bn
- IN₹1.41bn
- IN₹432.49m
- 37
- 20
- 95
- 49
Annual income statement for Raaj Medisafe India, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
R2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | PRESS |
Standards: | IAS | IAS | IAS | IAS | — |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 218 | 318 | 347 | 386 | 432 |
Cost of Revenue | |||||
Gross Profit | 66.5 | 99.8 | 116 | 118 | 140 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 206 | 284 | 302 | 337 | 374 |
Operating Profit | 11.7 | 33.6 | 45.2 | 48.8 | 58.5 |
Total Net Non Operating Interest Income / Expense | |||||
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 0.168 | 26.2 | 37.3 | 37.7 | 42.9 |
Provision for Income Taxes | |||||
Net Income After Taxes | -2.89 | 23 | 30.1 | 33.3 | 33.3 |
Net Income Before Extraordinary Items | |||||
Net Income | -2.89 | 23 | 30.1 | 33.3 | 33.3 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -2.89 | 23 | 30.1 | 33.3 | 33.3 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.562 | 2.11 | 2.72 | 3.04 | 3.07 |